Market Place
Sourcing Support
Steranco’s Generics Oxcarbazepine Receives Approval in US
09 Mar 2026 //
FDA
Contract Pharmacal’s Generics Famotidine Receives Approval in US
09 Mar 2026 //
FDA
Knack’s Generics Dexmedetomidine HCl Receives Approval in US
09 Mar 2026 //
FDA
Micro’s Generics Bisoprolol Fumarate Receives Approval in US
09 Mar 2026 //
FDA
E5 Pharma’s Generics Ivermectin Receives Approval in US
09 Mar 2026 //
FDA
Prinston’s Generics Gabapentin Receives Approval in US
06 Mar 2026 //
FDA
Aurobindo Pharma’s Generics Siponimod Receives Approval in US
06 Mar 2026 //
FDA
Anthea Pharma’s Generics Olanzapine Receives Approval in US
05 Mar 2026 //
FDA
Rubin Research’s Generics Ibuprofen Receives Approval in US
05 Mar 2026 //
FDA
Annora Pharma’s Generics Paroxetine HCl Receives Approval in US
05 Mar 2026 //
FDA
Micro’s Generics Cholestyramine Receives Approval in US
05 Mar 2026 //
FDA
Mylan’s Generics Aprepitant Receives Approval in US
05 Mar 2026 //
FDA
Puracap’s Generics Nintedanib Receives Tentative Approval in US
05 Mar 2026 //
FDA
Laurus’s Generics Emtricitabine Receives Approval in US
04 Mar 2026 //
FDA
Aspiro’s Generics Rocuronium Bromide Receives Approval in US
04 Mar 2026 //
FDA
Graviti Pharms’ Generics Glipizide Receives Approval in US
04 Mar 2026 //
FDA
Zydus’ Generics Calcitonin-Salmon Receives Approval in US
04 Mar 2026 //
FDA
Glenmark’s Generics Fluticasone Propionate Receive Approval in US
03 Mar 2026 //
FDA
Gland’s Generics Brimonidine Receives Tentative Approval in US
02 Mar 2026 //
FDA
Epic Pharma’s Generics Oxcarbazepine Receives Approval in US
02 Mar 2026 //
FDA
Apotex’s Generics Rivaroxaban Receives Approval in US
02 Mar 2026 //
FDA
Taro’s Generics Efinaconazole Receives Tentative Approval in US
02 Mar 2026 //
FDA
Macleods’ Generics Moxifloxacin HCl Receives Approval in US
02 Mar 2026 //
FDA
Shandong New Time’s Generics Brivaracetam Receives Approval in US
26 Feb 2026 //
FDA
Zydus’ Generics Ivermectin Receives Approval in US
26 Feb 2026 //
FDA
Ajanta Pharma’s Generics Empagliflozin Receives Approval in US
25 Feb 2026 //
FDA
Rubin Research’s Generics Cetirizine HCl Receives Approval in US
25 Feb 2026 //
FDA
App’s Generics Hydrocortisone Receives Approval in US
25 Feb 2026 //
FDA
Dr Reddy’s Generics Dexmedetomidine HCl Receives Approval in US
25 Feb 2026 //
FDA
Eton Pharma’s Desmoda Receives Approval in US
25 Feb 2026 //
FDA
Eugia Pharma’s Generics Everolimus Receives Approval in US
25 Feb 2026 //
FDA
Natco’s Generics Alectinib Receives Approval in US
25 Feb 2026 //
FDA
Cipla’s Generics Palbociclib Receives Approval in US
25 Feb 2026 //
FDA
Amneal Ireland’s Generics Macitentan Receives Approval in US
25 Feb 2026 //
FDA
App Pharma’s Generics Sodium Sulfate Receives Approval in US
24 Feb 2026 //
FDA
Aurobindo Pharma’s Generics Sitagliptin Receives Approval in US
24 Feb 2026 //
FDA
AQ USA Inc’s Receives FDA Warning Letter
24 Feb 2026 //
FDA
MedisourceRx’s Receives FDA Warning Letter
24 Feb 2026 //
FDA
Yichang Humanwell’s Generics Micafungin Receives Approval in US
24 Feb 2026 //
FDA
Orbicular’s Generics Liraglutide Receives Approval in US
24 Feb 2026 //
FDA
Biocon Pharma’s Generics Liraglutide Receives Approval in US
24 Feb 2026 //
FDA
Ajanta’s Generics Sitagliptin Phosphate Receives Approval in US
24 Feb 2026 //
FDA
Fourrts’ Generics Pregabalin Receives Approval in US
24 Feb 2026 //
FDA
Immedica Pharma’s Biologics Loargys Receives Approval in US
23 Feb 2026 //
FDA
Caplin’s Generics Sodium Phosphates Receives Approval in US
23 Feb 2026 //
FDA
Centaur Pharms’ Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Indoco’s Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Lupin’s Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Alkem’s Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Zhejiang Poly`s Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Hainan Poly’s Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Armstrong’ Generics Ipratropium Bromide Receives Approval in US
23 Feb 2026 //
FDA
Alkem’s Generics Sitagliptin Phosphate Receives Approval in US
23 Feb 2026 //
FDA
Micro’s Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Apotex’s Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Alembic’s Generics Efinaconazole Receives Approval in US
23 Feb 2026 //
FDA
Vanda Pharms’ Bysanti Receives Approval in US
20 Feb 2026 //
FDA
Avyxa’s Favlyxa Receives Approval in US
20 Feb 2026 //
FDA
Invagen Pharms’ Generics Rivaroxaban Receives Approval in US
20 Feb 2026 //
FDA
Teva Pharms’ Generics Linagliptin Receives Approval in US
20 Feb 2026 //
FDA
